Quantitative Electrochemiluminescent Immunoassay
Within 24 hours
New York DOH Approval Status
Serum separator tube, plasma separator tube, green (lithium heparin), lavender (K2 or K3 EDTA), or pink (K2 EDTA)
Allow specimen to clot completely at room temperature. Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.6 mL)
Refrigerated. Also acceptable: Frozen.
Body Fluid (refer to Carcinoembryonic Antigen, Fluid, ARUP test code 0020742).
After separation from cells: Ambient: 7 days; Refrigerated: 2 weeks; Frozen: 6 months
Effective February 22, 2022
|0-20 years||No Ranges|
|20-69 years||0.0 - 3.8 ng/mL|
|69-150 years||No Ranges|
The Roche CEA electrochemiluminescent immunoassay is used. Results obtained with different test methods or kits cannot be used interchangeably. Measurement of CEA has been shown to be clinically relevant in the management of patients with colorectal, breast, lung, prostatic, pancreatic, and ovarian carcinomas. Smokers may have slightly elevated levels of CEA. The CEA assay value, regardless of level, should not be interpreted as evidence for the presence or absence of malignant disease and is not recommended for use as a screening procedure to detect the presence of cancer in the general population.
|Component Test Code*||Component Chart Name||LOINC|
- Carcinoembryonic Antigen
- CEA Assay
- CEA Levels
- CEA, Serum
- Embryonic Carcinoma Antigen